Intuitive Surgical stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 82 to 91.
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an RS Rating north of 80 in the early stages of their moves.
Here Are 3 Keys For Successful Stock Investing
Is Intuitive Surgical Stock A Buy?
The IBD 50 stock is now considered extended and out of buy range after clearing a 403.76 buy point in a third-stage flat base. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The robotic surgery device maker saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 22% to 25%. Revenue rose from 11% to 14%.
Intuitive Surgical stock holds the No. 3 rank among its peers in the Medical-Systems/Equipment industry group. Electromed is the No. 1-ranked stock within the group.
